403 related articles for article (PubMed ID: 25339657)
1. CD44 variant isoforms expressed by breast cancer cells are functional E-selectin ligands under flow conditions.
Shirure VS; Liu T; Delgadillo LF; Cuckler CM; Tees DF; Benencia F; Goetz DJ; Burdick MM
Am J Physiol Cell Physiol; 2015 Jan; 308(1):C68-78. PubMed ID: 25339657
[TBL] [Abstract][Full Text] [Related]
2. Carcinoembryonic antigen and CD44 variant isoforms cooperate to mediate colon carcinoma cell adhesion to E- and L-selectin in shear flow.
Thomas SN; Zhu F; Schnaar RL; Alves CS; Konstantopoulos K
J Biol Chem; 2008 Jun; 283(23):15647-55. PubMed ID: 18375392
[TBL] [Abstract][Full Text] [Related]
3. Selectin ligand expression regulates the initial vascular interactions of colon carcinoma cells: the roles of CD44v and alternative sialofucosylated selectin ligands.
Napier SL; Healy ZR; Schnaar RL; Konstantopoulos K
J Biol Chem; 2007 Feb; 282(6):3433-41. PubMed ID: 17135256
[TBL] [Abstract][Full Text] [Related]
4. Podocalyxin-like protein is an E-/L-selectin ligand on colon carcinoma cells: comparative biochemical properties of selectin ligands in host and tumor cells.
Thomas SN; Schnaar RL; Konstantopoulos K
Am J Physiol Cell Physiol; 2009 Mar; 296(3):C505-13. PubMed ID: 19118161
[TBL] [Abstract][Full Text] [Related]
5. Mac-2 binding protein is a novel E-selectin ligand expressed by breast cancer cells.
Shirure VS; Reynolds NM; Burdick MM
PLoS One; 2012; 7(9):e44529. PubMed ID: 22970241
[TBL] [Abstract][Full Text] [Related]
6. The effect of soluble E-selectin on tumor progression and metastasis.
Kang SA; Blache CA; Bajana S; Hasan N; Kamal M; Morita Y; Gupta V; Tsolmon B; Suh KS; Gorenstein DG; Razaq W; Rui H; Tanaka T
BMC Cancer; 2016 May; 16():331. PubMed ID: 27220365
[TBL] [Abstract][Full Text] [Related]
7. Variant isoforms of CD44 are P- and L-selectin ligands on colon carcinoma cells.
Hanley WD; Napier SL; Burdick MM; Schnaar RL; Sackstein R; Konstantopoulos K
FASEB J; 2006 Feb; 20(2):337-9. PubMed ID: 16352650
[TBL] [Abstract][Full Text] [Related]
8. CD44 on LS174T colon carcinoma cells possesses E-selectin ligand activity.
Hanley WD; Burdick MM; Konstantopoulos K; Sackstein R
Cancer Res; 2005 Jul; 65(13):5812-7. PubMed ID: 15994957
[TBL] [Abstract][Full Text] [Related]
9. A Glycovariant of Human CD44 is Characteristically Expressed on Human Mesenchymal Stem Cells.
Pachón-Peña G; Donnelly C; Ruiz-Cañada C; Katz A; Fernández-Veledo S; Vendrell J; Sackstein R
Stem Cells; 2017 Apr; 35(4):1080-1092. PubMed ID: 27888602
[TBL] [Abstract][Full Text] [Related]
10. Gangliosides expressed on breast cancer cells are E-selectin ligands.
Shirure VS; Henson KA; Schnaar RL; Nimrichter L; Burdick MM
Biochem Biophys Res Commun; 2011 Mar; 406(3):423-9. PubMed ID: 21329670
[TBL] [Abstract][Full Text] [Related]
11. A functional glycoproteomics approach identifies CD13 as a novel E-selectin ligand in breast cancer.
Carrascal MA; Silva M; Ferreira JA; Azevedo R; Ferreira D; Silva AMN; Ligeiro D; Santos LL; Sackstein R; Videira PA
Biochim Biophys Acta Gen Subj; 2018 Sep; 1862(9):2069-2080. PubMed ID: 29777742
[TBL] [Abstract][Full Text] [Related]
12. CD44 is a major E-selectin ligand on human hematopoietic progenitor cells.
Dimitroff CJ; Lee JY; Rafii S; Fuhlbrigge RC; Sackstein R
J Cell Biol; 2001 Jun; 153(6):1277-86. PubMed ID: 11402070
[TBL] [Abstract][Full Text] [Related]
13. Isoform switch of CD44 induces different chemotactic and tumorigenic ability in gallbladder cancer.
Miwa T; Nagata T; Kojima H; Sekine S; Okumura T
Int J Oncol; 2017 Sep; 51(3):771-780. PubMed ID: 28677740
[TBL] [Abstract][Full Text] [Related]
14. TGF-β1 promotes epithelial-to-mesenchymal transition and stemness of prostate cancer cells by inducing PCBP1 degradation and alternative splicing of CD44.
Chen Q; Gu M; Cai ZK; Zhao H; Sun SC; Liu C; Zhan M; Chen YB; Wang Z
Cell Mol Life Sci; 2021 Feb; 78(3):949-962. PubMed ID: 32440711
[TBL] [Abstract][Full Text] [Related]
15. CD44: structure, function, and association with the malignant process.
Naor D; Sionov RV; Ish-Shalom D
Adv Cancer Res; 1997; 71():241-319. PubMed ID: 9111868
[TBL] [Abstract][Full Text] [Related]
16. CD44v4 is a major E-selectin ligand that mediates breast cancer cell transendothelial migration.
Zen K; Liu DQ; Guo YL; Wang C; Shan J; Fang M; Zhang CY; Liu Y
PLoS One; 2008 Mar; 3(3):e1826. PubMed ID: 18350162
[TBL] [Abstract][Full Text] [Related]
17. Blocking the adhesion cascade at the premetastatic niche for prevention of breast cancer metastasis.
Kang SA; Hasan N; Mann AP; Zheng W; Zhao L; Morris L; Zhu W; Zhao YD; Suh KS; Dooley WC; Volk D; Gorenstein DG; Cristofanilli M; Rui H; Tanaka T
Mol Ther; 2015 Jun; 23(6):1044-1054. PubMed ID: 25815697
[TBL] [Abstract][Full Text] [Related]
18. HCELL is the major E- and L-selectin ligand expressed on LS174T colon carcinoma cells.
Burdick MM; Chu JT; Godar S; Sackstein R
J Biol Chem; 2006 May; 281(20):13899-905. PubMed ID: 16565092
[TBL] [Abstract][Full Text] [Related]
19. Selectin ligand sialyl-Lewis x antigen drives metastasis of hormone-dependent breast cancers.
Julien S; Ivetic A; Grigoriadis A; QiZe D; Burford B; Sproviero D; Picco G; Gillett C; Papp SL; Schaffer L; Tutt A; Taylor-Papadimitriou J; Pinder SE; Burchell JM
Cancer Res; 2011 Dec; 71(24):7683-93. PubMed ID: 22025563
[TBL] [Abstract][Full Text] [Related]
20. Silencing α1,3-fucosyltransferases in human leukocytes reveals a role for FUT9 enzyme during E-selectin-mediated cell adhesion.
Buffone A; Mondal N; Gupta R; McHugh KP; Lau JT; Neelamegham S
J Biol Chem; 2013 Jan; 288(3):1620-33. PubMed ID: 23192350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
